BA
The Boeing Company
BA has the edge over BHST overall, supported by lower modeled downside and stronger fundamentals.
BHST
BioHarvest Sciences Inc.
BHST offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
BHST Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Unavailable |
BHST's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
BHST PE Valuation
BHST has no meaningful PE right now: it lost money over the past year.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
BHST Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect BHST's losses to shrink, with revenue growing.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over BHST on earnings quality, reporting a profit while its opponent remains loss making.
BHST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.54 | +$0.16 |
| Q1 2026 | -$0.62 | -$0.12 |
| Q4 2025 | -$0.63 | +$0.22 |
| Q3 2025 | -$0.68 | +$0.54 |
| Q2 2025 | -$0.70 | +$0.49 |
| Q1 2025 | -$0.50 | +$0.86 |
| Q4 2024 | -$0.85 | +$0.09 |
| Q3 2024 | -$1.22 | -$0.61 |
BHST is still losing money, but far less than before: $0.54 per share over the past year, against $1.36 at its worst in early 2024.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA has the edge over BHST on profitability, with a higher operating margin.
BHST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $8.8M | +3.8% |
| Q1 2026 | $8.5M | +8.2% |
| Q4 2025 | $9.1M | +25% |
| Q3 2025 | $9.1M | +39% |
| Q2 2025 | $8.5M | +41% |
| Q1 2025 | $7.9M | +47% |
| Q4 2024 | $7.3M | +61% |
| Q3 2024 | $6.5M | +102% |
BHST has the edge over BA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -28% | -7.1 points |
| Q1 2026 | -22% | +0.3 points |
| Q4 2025 | -12% | +11 points |
| Q3 2025 | -10% | +22 points |
| Q2 2025 | -21% | +8.1 points |
| Q1 2025 | -22% | +4.8 points |
| Q4 2024 | -23% | +33 points |
| Q3 2024 | -32% | +30 points |
BHST's operating margin was −28% last quarter, down 7.1 points from the same quarter a year ago.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over BHST on cash generation, producing positive trailing cash flow while its opponent burns cash.
BHST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.3M | -$1.2M |
| Q1 2026 | -$2.2M | -$59K |
| Q4 2025 | -$2.9M | +$387.3K |
| Q3 2025 | -$2.5M | -$270.7K |
| Q2 2025 | -$2.1M | +$542.1K |
| Q1 2025 | -$2.1M | -$311K |
| Q4 2024 | -$3.3M | -$126.9K |
| Q3 2024 | -$2.3M | -$836K |
BHST has burned cash in almost every quarter: −$11M over the past year, against −$10M the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has the edge over BHST on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
BHST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +477 shares |
| 1 year | +31% | +5.3M shares |
| 3 years | +69% | +9.2M shares |
| 5 years | +84% | +10.3M shares |
| Available history | +698% | +19.8M shares |
BHST has 23M diluted shares, up 31% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BHST hasn't bought back shares in the past year.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
BHST Net Leverage
BHST's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
BHST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.6 | Neutral |
| Stochastic | 17.3 | Oversold |
BHST's weekly RSI is 33 (neutral) and its Stochastic is 17 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
BHST PE vs Industrials Sector
BHST has no meaningful PE right now: it lost money over the past year.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BHST has stronger trend alignment. BA is above 0 of 5 weekly averages versus BHST above 1 of 4.
BHST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.63 | 0% above |
| 20 week MA | $1.97 | 17% below |
| 50 week MA | $3.45 | 53% below |
| 100 week MA | $5.30 | 69% below |
BHST is in a downtrend: it's below all four of its weekly moving averages, and 69% below its 100-week average.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has the edge over BHST on returns for 2026, with the stronger performance.
BHST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $4.80 | $6.15 | +28% |
| 2025 | $6.15 | $5.33 | -13% |
| 2026 YTD | $5.33 | $1.63 | -69% |
BHST has finished lower in one of the last two years. It's down 69% so far in 2026.